Torqur Partners With Lonza For Advanced Stage Development
01 Apr 2026 //
INDPHARMAPOST
Bimiralisib Demonstrates 92% Clearance Rate In Actinic Keratosis
06 Oct 2025 //
PHARMAWEB
Torqur AG Presents Ph2 Data At AAD 2025 Annual Meeting
07 Mar 2025 //
BUSINESSWIRE

Market Place
Sourcing Support